CIS, LUCA
 Distribuzione geografica
Continente #
AS - Asia 52
NA - Nord America 42
EU - Europa 32
SA - Sud America 6
Totale 132
Nazione #
US - Stati Uniti d'America 38
SG - Singapore 20
IT - Italia 13
CN - Cina 10
VN - Vietnam 8
HK - Hong Kong 7
BR - Brasile 6
NL - Olanda 4
FI - Finlandia 3
FR - Francia 3
GB - Regno Unito 3
CA - Canada 2
DE - Germania 2
JP - Giappone 2
BD - Bangladesh 1
BE - Belgio 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
MX - Messico 1
PH - Filippine 1
PK - Pakistan 1
UA - Ucraina 1
Totale 132
Città #
Singapore 11
Hong Kong 7
Ashburn 5
Beijing 5
Ho Chi Minh City 5
Los Angeles 5
San Jose 5
Dallas 3
Lauterbourg 3
Manchester 3
Milan 3
Brescia 2
Brooklyn 2
Frankfurt am Main 2
Lappeenranta 2
Padova 2
Rio de Janeiro 2
Rome 2
Tokyo 2
Amman 1
Amsterdam 1
Araras 1
Belford Roxo 1
Brussels 1
Bắc Giang 1
Calgary 1
Cavallino 1
Council Bluffs 1
Elk Grove Village 1
Fortaleza 1
Hanoi 1
Helsinki 1
Houston 1
Hải Dương 1
Kilkenny 1
Kissimmee 1
Kyiv 1
Madrid 1
Manaus 1
Manila 1
Mexico City 1
New York 1
Olathe 1
Orem 1
Peshawar 1
Santa Clara 1
St. Thomas 1
Turin 1
Warsaw 1
Wilmington 1
Totale 102
Nome #
Abstract 2977: Novel HSP90 inhibitors with senolytic activity for a targeted therapy in a hormone-induced breast cancer senescence model 65
LCM-RNAseq Highlights Intratumor Heterogeneity and a lncRNA Signature from Archival Tissues of GH-Secreting PitNETs 53
A Feasibility Study of Co-Established Patient-Derived Subcutaneous Xenograft and Organotypic Slice Cultures in Hormone-Naive Primary Prostate Cancer Preclinical Modeling: A Single-Institution Experience 22
Totale 140
Categoria #
all - tutte 370
article - articoli 197
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202548 0 0 0 0 0 14 4 6 3 5 11 5
2025/202689 3 8 4 8 16 15 9 3 6 15 2 0
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 140